🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Larisa V. Gubareva

Centers for Disease Control and Prevention

ORCID: 0000-0002-3136-5550
MedicineAgricultural and Biological SciencesBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 1%percentile
5.0Author DataRank

Indexed papers

1in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology
Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 1 indexed paper attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

Top data-sharing exemplar

The highest-impact dataset this researcher has shared, ranked by DataRank — the single contribution doing the most to lift their data-sharing standing.

Global update on the susceptibilities of human influenza viruses to neuraminidase inhibitors and the cap-dependent endonuclease inhibitor baloxavir, 2018–2020

Antiviral Research(2022)10.1016/j.antiviral.2022.105281
Top 4%
5.0DataRank
Top 4%143 citations

Emi Takashita, Rod S. Daniels, Seiichiro Fujisaki, Lance Presser, Mira C. Patel +16 more

Papers

Driven by 10 papers — median percentile 96. Top paper: “Global update on the susceptibilities of human influenza viruses to neuraminidase inhibitors and the cap-dependent endonuclease inhibitor baloxavir, 2018–2020”.

Global update on the susceptibilities of human influenza viruses to neuraminidase inhibitors and the cap-dependent endonuclease inhibitor baloxavir, 2018–2020

Antiviral Research(2022)10.1016/j.antiviral.2022.105281
Top 4%
5.0DataRank
Top 4%143 citations

Emi Takashita, Rod S. Daniels, Seiichiro Fujisaki, Lance Presser, Mira C. Patel +16 more

Influenza polymerase inhibitor resistance: Assessment of the current state of the art - A report of the isirv Antiviral group

Antiviral Research(2021)10.1016/j.antiviral.2021.105158
N/A
0DataRank · unranked
42 citations

Frederick G. Hayden, Alan Hay, Larisa V. Gubareva, Elena A. Govorkova, Emi Takashita +2 more

Susceptibility of widely diverse influenza a viruses to PB2 polymerase inhibitor pimodivir

Antiviral Research(2021)10.1016/j.antiviral.2021.105035
N/A
0DataRank · unranked
28 citations

Anton Chesnokov, Joyce Jones, Vasiliy P. Mishin, Juan A. De La Cruz, Ha Nguyen +5 more

An optimized cell-based assay to assess influenza virus replication by measuring neuraminidase activity and its applications for virological surveillance

Antiviral Research(2022)10.1016/j.antiviral.2022.105457
N/A
0DataRank · unranked
20 citations

D. Flanigan, Chenchen Feng, Anton Chesnokov, Ha Nguyen, Anwar Abd Elal +6 more

Antiviral susceptibility of clade 2.3.4.4b highly pathogenic avian influenza A(H5N1) viruses isolated from birds and mammals in the United States, 2022

Antiviral Research(2023)10.1016/j.antiviral.2023.105679
N/A
0DataRank · unranked
38 citations

Anton Chesnokov, Juan De La Cruz, Philippe Noriel Q. Pascua, Vasiliy P. Mishin, Yunho Jang +11 more

New insights into the neuraminidase-mediated hemagglutination activity of influenza A(H3N2) viruses

Antiviral Research(2023)10.1016/j.antiviral.2023.105719
N/A
0DataRank · unranked
6 citations

Philippe Noriel Q. Pascua, Ha T Nguyen, Anton Chesnokov, C I Champion, Vasiliy P. Mishin +3 more

Human infections with highly pathogenic avian influenza A(H5N1) viruses in the United States from March 2024 to May 2025

Nature Medicine(2025)10.1038/s41591-025-03905-2
N/A
0DataRank · unranked
36 citations

Krista Kniss, Marie K. Kirby, Shikha Garg, Katie Reinhart, C. Todd Davis +75 more

Global update on the susceptibilities of influenza viruses to neuraminidase inhibitors and the cap-dependent endonuclease inhibitor baloxavir, 2020–2023

Antiviral Research(2025)10.1016/j.antiviral.2025.106217
N/A
0DataRank · unranked
17 citations

Adam Meijer, Elena A. Govorkova, Clyde Dapat, Larisa V. Gubareva, Ian Barr +20 more

Global update on the susceptibilities of human influenza viruses to neuraminidase inhibitors and the cap-dependent endonuclease inhibitor baloxavir, 2017–2018

Antiviral Research(2020)10.1016/j.antiviral.2020.104718
N/A
0DataRank · unranked
129 citations

Rod S. Daniels, Seiichiro Fujisaki, Vicki L. Gregory, Larisa V. Gubareva, Weiijuan Huang +13 more

Antiviral susceptibility monitoring: testing algorithm, methods, and findings for influenza season, 2023–2024

Antiviral Research(2025)10.1016/j.antiviral.2025.106299
N/A
0DataRank · unranked
1 citations

Ha T Nguyen, Vasiliy P. Mishin, Philippe Noriel Q. Pascua, C I Champion, Mercedes Lopez-Esteva +12 more